Jane Street
TYRA icon

Jane Street’s Tyra Biosciences TYRA Stock Holding History

Jane Street’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.37M Buy
+61,900
New +$2M ﹤0.01% 4763

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Jane Street's TYRA Position: Q1 2026 in Review

Jane Street opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 10,169 shares worth $389K. The stake represents ﹤0.01% of the portfolio and ranks #8612 among its holdings. This is a return to the name: Jane Street previously reported a position in TYRA as recently as Q3 2025.

Jane Street first reported a position in TYRA in Q2 2024 and has held it in 6 quarters since. The position peaked at $729K in Q3 2024. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Jane Street held 10,169 shares of Tyra Biosciences worth $389K as of Q1 2026.
  • Tyra Biosciences was a new Jane Street position in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8612 holding.
  • Jane Street first reported a position in Tyra Biosciences in Q2 2024 and has held it in 6 quarters since.
  • Jane Street's Tyra Biosciences position peaked at $729K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.